Competency Map: Pharmacist

  • B: BASIC GENETIC CONCEPTS
    • B1: To demonstrate an understanding of the basic genetic/genomic concepts and nomenclature
      • University of Utah Genetic Science Learning Center
      • Human Genome Program of the Department of Energy
      • Genome-Wide Association Studies Fact Sheet
      • Genetics Home Reference
      • Physician Data Query (PDQ) Cancer Information Summaries: Genetics – National Cancer Institute
      • Center for Genetics Education – Basic Genetic Fact Sheets
      • Labtests Online
      • Pharmacogenomics Research Site
      • Pharmacogenomics: Applications to Patient Care
      • Pharmacogenomics: from the ground up
      • Pharmaco-What? Introducing Personalized Medicine
      • Personalized Medicine Coalition
      • Evaluation of Genomic Applications in Practice and Prevention
      • Genetics Home Reference
      • Pharmacogenomics: Applications to Patient Care, second edition
      • Pharmacogenomics: An Introduction and Clinical Perspective
      • ASHP Emerging Sciences Resource Center
      • Concepts in Pharmacogenomics
      • Principles of the Human Genome and Pharmacogenomics
      • Principles of Pharmacogenetics and Pharmacogenomics
      • Pharmacogenetics – five decades of therapeutic lessons from genetic diversity
      • Bringing genome-wide association findings into clinical use
      • Pharmacogenomics Education Program (PharmGenEd)
      • Pharmacogenomics: Applications to Patient Care, third edition
    • B2: To recognize and appreciate the role of behavioral, social, and environmental factors (lifestyle, socioeconomic factors, pollutants, etc.) to modify or influence genetics in the manifestation of disease
      • University of Utah Genetic Science Learning Center
      • Human Genome Program of the Department of Energy
      • Genetics Home Reference
      • Pharmacogenomics: Applications to Patient Care
      • Evaluation of Genomic Applications in Practice and Prevention
      • Genetics Home Reference
      • Pharmacogenomics Challenges and Opportunities in Therapeutic Implementation
      • Principles of the Human Genome and Pharmacogenomics
      • Pharmacogenomics Education Program (PharmGenEd)
    • B3: To identify drug and disease associated genetic variations that facilitate development of prevention, diagnostic and treatment strategies and appreciate there are differences in testing methodologies and are aware of the need to explore these differences these differences in drug literature evaluation
      • University of Utah Genetic Science Learning Center
      • Pharmacogenomics: Applications to Patient Care
      • Pharmaco-What? Introducing Personalized Medicine
      • Pharmacogenomics: Applications to Patient Care, second edition
      • Pharmacogenomics: An Introduction and Clinical Perspective
      • Pharmacogenomics Challenges and Opportunities in Therapeutic Implementation
      • Clopidogrel
      • Warfarin
      • Thiopurines (Azathioprine, Mercaptopurine and Thioguanine)
      • ASHP Emerging Sciences Resource Center
      • Concepts in Pharmacogenomics
      • Principles of the Human Genome and Pharmacogenomics
      • Psychiatric Pharmacogenomics
      • Principles of Pharmacogenetics and Pharmacogenomics
      • Pharmacogenetics: from bench to byte–an update of guidelines.
      • Bringing genome-wide association findings into clinical use
      • Pharmacogenomics: Applications to Patient Care, third edition
    • B4: To use family history (minimum of three generations) in assessing predisposition to disease and selection of drug treatment
      • University of Utah Genetic Science Learning Center
      • Human Genome Program of the Department of Energy
      • Genetics Home Reference
      • NCHPEG – Competencies in Family History
      • Evaluation of Genomic Applications in Practice and Prevention
      • Genetics Home Reference
      • Principles of the Human Genome and Pharmacogenomics
      • Psychiatric Pharmacogenomics
  • G: GENETICS AND DISEASE
    • G1: To understand the role of genetic factors in maintaining health and preventing disease
      • Human Genome Program of the Department of Energy
      • Physician Data Query (PDQ) Cancer Information Summaries: Genetics – National Cancer Institute
      • Center for Genetics Education – Basic Genetic Fact Sheets
      • Pharmacogenomics: Applications to Patient Care
      • Personalized Medicine Coalition
      • Evaluation of Genomic Applications in Practice and Prevention
      • Pharmacogenomics: Applications to Patient Care, second edition
      • Pharmacogenomics: An Introduction and Clinical Perspective
      • Pharmacogenomics Challenges and Opportunities in Therapeutic Implementation
      • Psychiatric Pharmacogenomics
      • The emerging role of electronic medical records in pharmacogenomics
      • Pharmacogenomics: Applications to Patient Care, third edition
    • G2: To assess the difference between clinical diagnosis of disease and identification of genetic predisposition to disease (genetic variation is not strictly correlated with disease manifestation)
      • Human Genome Program of the Department of Energy
      • Genome-Wide Association Studies Fact Sheet
      • Physician Data Query (PDQ) Cancer Information Summaries: Genetics – National Cancer Institute
      • Center for Genetics Education – Basic Genetic Fact Sheets
      • Personalized Medicine Coalition
      • Evaluation of Genomic Applications in Practice and Prevention
      • Pharmacogenomics: Applications to Patient Care, second edition
      • Pharmacogenomics Challenges and Opportunities in Therapeutic Implementation
      • Psychiatric Pharmacogenomics
      • Bringing genome-wide association findings into clinical use
      • Pharmacogenomics: Applications to Patient Care, third edition
    • G3: To appreciate that pharmacogenomic testing may also reveal certain genetic disease predispositions (e.g. the Apo E4 polymorphism)
      • Cancer Topics: National Cancer Institute
      • Human Genome Program of the Department of Energy
      • Genome-Wide Association Studies Fact Sheet
      • Physician Data Query (PDQ) Cancer Information Summaries: Genetics – National Cancer Institute
      • Center for Genetics Education – Basic Genetic Fact Sheets
      • Pharmacogenomics: Applications to Patient Care, second edition
      • Pharmacogenomics Challenges and Opportunities in Therapeutic Implementation
      • Psychiatric Pharmacogenomics
      • Pharmacogenomics Education Program (PharmGenEd)
      • Pharmacogenomics: Applications to Patient Care, third edition
  • P: PHARMACOGENETICS/PHARMACOGENOMICS
    • P1: To demonstrate an understanding of how genetic variation in a large number of proteins, including drug transporters, drug metabolizing enzymes, direct protein targets of drugs, and other proteins (e.g. signal transduction proteins) influence pharmacokinetics and pharmacodynamics related to pharmacologic effect and drug response
      • Labtests Online
      • Pharmacogenomics Research Site
      • Pharmacogenomics: Applications to Patient Care
      • Pharmacogenomics: from the ground up
      • Personalized Medicine Coalition
      • Pharmacogenomics: Applications to Patient Care, second edition
      • Pharmacogenetics, Kinetics, and Dynamics for Personalized Medicine
      • Pharmacogenomics: An Introduction and Clinical Perspective
      • Clopidogrel
      • Warfarin
      • Thiopurines (Azathioprine, Mercaptopurine and Thioguanine)
      • ASHP Emerging Sciences Resource Center
      • Concepts in Pharmacogenomics
      • Principles of the Human Genome and Pharmacogenomics
      • Principles of Pharmacogenetics and Pharmacogenomics
      • Pharmacogenetics – five decades of therapeutic lessons from genetic diversity
      • The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Overcoming Challenges of Real-World Implementation.
      • Pharmacogenomics and individualized medicine: translating science into practice
      • Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project
      • The 1200 patients project: creating a new medical model system for clinical implementation of pharmacogenomics
      • *A clinician-driven automated system for integration of pharmacogenetic interpretations into an electronic medical record.
      • The emerging role of electronic medical records in pharmacogenomics
      • Pharmacogenetics: from bench to byte–an update of guidelines.
      • Development and implementation of a pharmacist-managed clinical pharmacogenetics service
      • Optimizing drug outcomes through pharmacogenetics: a case for preemptive genotyping
      • Bringing genome-wide association findings into clinical use
      • Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for thiopurine methyltransferase genotype and thiopurine dosing
      • Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update
      • Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing
      • Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for Cytochrome P450 2D6 (CYP2D6) genotype and codeine therapy
      • Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for HLA-B genotype and abacavir dosing
      • Clinical Pharmacogenomics Implementation Consortium (CPIC) guidelines for SLCO1B1 and simvastatin-induced myopathy
      • Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for human leukocyte antigen-B genotype and allopurinol dosing
      • Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants
      • Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for HLA-B Genotype and Carbamazepine Dosing
      • Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing
      • Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for IFNL3 (IL28B) Genotype and PEG Interferon–Based Regimens
      • A clinician-driven automated system for integration of pharmacogenetic interpretations into an electronic medical record.
      • Pharmacogenomics Education Program (PharmGenEd)
      • Pharmacogenomics: Applications to Patient Care, third edition
      • Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for Ivacaftor Therapy in the context of CFTR genotype
      • Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for Rasburicase Therapy in the context of G6PD deficiency genotype
      • Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for CYP2C9 and HLA-B genotype and Phenytoin dosing
      • Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 Genotype and Dosing of Selective Serotonin Reuptake Inhibitor Paroxetine
      • Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 Genotype and Dosing of Selective Serotonin Reuptake Inhibitor Fluvoxamine
      • Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 Genotype and Dosing of Selective Serotonin Reuptake Inhibitor Citalopram/Escitalopram
      • Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 Genotype and Dosing of Selective Serotonin Reuptake Inhibitor Sertraline
    • P2: To understand the influence (or lack thereof) of ethnicity in genetic polymorphisms and associations of polymorphisms with drug response
      • Pharmacogenomics: Applications to Patient Care
      • Pharmacogenomics: Applications to Patient Care, second edition
      • Pharmacogenetics, Kinetics, and Dynamics for Personalized Medicine
      • Pharmacogenomics: An Introduction and Clinical Perspective
      • ASHP Emerging Sciences Resource Center
      • Concepts in Pharmacogenomics
      • Principles of the Human Genome and Pharmacogenomics
      • Principles of Pharmacogenetics and Pharmacogenomics
      • Pharmacogenetics – five decades of therapeutic lessons from genetic diversity
      • Pharmacogenomics and individualized medicine: translating science into practice
      • Optimizing drug outcomes through pharmacogenetics: a case for preemptive genotyping
      • Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for thiopurine methyltransferase genotype and thiopurine dosing
      • Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update
      • Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing
      • Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for Cytochrome P450 2D6 (CYP2D6) genotype and codeine therapy
      • Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for HLA-B genotype and abacavir dosing
      • Clinical Pharmacogenomics Implementation Consortium (CPIC) guidelines for SLCO1B1 and simvastatin-induced myopathy
      • Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for human leukocyte antigen-B genotype and allopurinol dosing
      • Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants
      • Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for HLA-B Genotype and Carbamazepine Dosing
      • Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing
      • Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for IFNL3 (IL28B) Genotype and PEG Interferon–Based Regimens
      • Pharmacogenomics Education Program (PharmGenEd)
      • Pharmacogenomics: Applications to Patient Care, third edition
      • Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for Ivacaftor Therapy in the context of CFTR genotype
      • Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for Rasburicase Therapy in the context of G6PD deficiency genotype
      • Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for CYP2C9 and HLA-B genotype and Phenytoin dosing
      • Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 Genotype and Dosing of Selective Serotonin Reuptake Inhibitor Paroxetine
      • Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 Genotype and Dosing of Selective Serotonin Reuptake Inhibitor Fluvoxamine
      • Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 Genotype and Dosing of Selective Serotonin Reuptake Inhibitor Citalopram/Escitalopram
      • Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 Genotype and Dosing of Selective Serotonin Reuptake Inhibitor Sertraline
    • P3: Recognize the availability of evidence based guidelines that synthesize information relevant to genomic/pharmacogenomic tests and selection of drug therapy (e.g. Clinical Pharmacogenomics Implementation Consortium)
      • Evaluation of Genomic Applications in Practice and Prevention
      • Pharmacogenetics, Kinetics, and Dynamics for Personalized Medicine
      • Pharmacogenomics: An Introduction and Clinical Perspective
      • ASHP Emerging Sciences Resource Center
      • Concepts in Pharmacogenomics
      • Principles of Pharmacogenetics and Pharmacogenomics
      • Pharmacogenomics and individualized medicine: translating science into practice
      • Pharmacogenetics: from bench to byte–an update of guidelines.
      • Optimizing drug outcomes through pharmacogenetics: a case for preemptive genotyping
      • Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for thiopurine methyltransferase genotype and thiopurine dosing
      • Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update
      • Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing
      • Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for Cytochrome P450 2D6 (CYP2D6) genotype and codeine therapy
      • Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for HLA-B genotype and abacavir dosing
      • Clinical Pharmacogenomics Implementation Consortium (CPIC) guidelines for SLCO1B1 and simvastatin-induced myopathy
      • Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for human leukocyte antigen-B genotype and allopurinol dosing
      • Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants
      • Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for HLA-B Genotype and Carbamazepine Dosing
      • Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing
      • Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for IFNL3 (IL28B) Genotype and PEG Interferon–Based Regimens
      • Pharmacogenomics Education Program (PharmGenEd)
      • Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for Ivacaftor Therapy in the context of CFTR genotype
      • Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for Rasburicase Therapy in the context of G6PD deficiency genotype
      • Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for CYP2C9 and HLA-B genotype and Phenytoin dosing
      • Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 Genotype and Dosing of Selective Serotonin Reuptake Inhibitor Paroxetine
      • Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 Genotype and Dosing of Selective Serotonin Reuptake Inhibitor Fluvoxamine
      • Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 Genotype and Dosing of Selective Serotonin Reuptake Inhibitor Citalopram/Escitalopram
      • Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 Genotype and Dosing of Selective Serotonin Reuptake Inhibitor Sertraline
  • E: ETHICAL, LEGAL AND SOCIAL IMPLICATIONS (ELSI)
    • E1: To understand the potential physical and/or psychosocial benefits, limitations and risk of genomic/pharmacogenomic information for individuals, family members and communities, especially with genomic/pharmacogenomic tests that may relate to predisposition to disease
      • National Human Genome Research Institute – Fact Sheets About Science, Ethics, Research Technique and Institute
      • Secretary’s Advisory Committee on Genetics, Health, and Society
      • Pharmacogenomics: Applications to Patient Care, second edition
      • Pharmacogenomics: An Introduction and Clinical Perspective
      • Pharmacogenomics Challenges and Opportunities in Therapeutic Implementation
      • Concepts in Pharmacogenomics
      • Psychiatric Pharmacogenomics
      • Principles of Pharmacogenetics and Pharmacogenomics
      • Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project
      • Pharmacogenomics Education Program (PharmGenEd)
      • Pharmacogenomics: Applications to Patient Care, third edition
    • E2: To understand the increased liability that accompanies access to detailed genomic patient information and maintain confidentiality and security
      • National Human Genome Research Institute – Fact Sheets About Science, Ethics, Research Technique and Institute
      • Secretary’s Advisory Committee on Genetics, Health, and Society
      • Pharmacogenomics: Applications to Patient Care
      • Pharmacogenomics: Applications to Patient Care, second edition
      • Pharmacogenomics: An Introduction and Clinical Perspective
      • Concepts in Pharmacogenomics
      • Principles of Pharmacogenetics and Pharmacogenomics
      • Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project
      • Pharmacogenomics: Applications to Patient Care, third edition
    • E3: To adopt a culturally sensitive and ethical approach to patient counseling regarding genomic/pharmacogenomic test results
      • National Human Genome Research Institute – Fact Sheets About Science, Ethics, Research Technique and Institute
      • Secretary’s Advisory Committee on Genetics, Health, and Society
      • Pharmacogenomics: An Introduction and Clinical Perspective
      • Clopidogrel
      • Warfarin
      • Thiopurines (Azathioprine, Mercaptopurine and Thioguanine)
      • ASHP Emerging Sciences Resource Center
      • Principles of Pharmacogenetics and Pharmacogenomics
      • The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Overcoming Challenges of Real-World Implementation.
      • *A clinician-driven automated system for integration of pharmacogenetic interpretations into an electronic medical record.
      • Development and implementation of a pharmacist-managed clinical pharmacogenetics service
      • A clinician-driven automated system for integration of pharmacogenetic interpretations into an electronic medical record.
    • E4: To appreciate the cost, cost-effectiveness, and reimbursement by insurers relevant to genomic or pharmacogenomic tests and test interpretation, for patients and populations
      • National Human Genome Research Institute – Fact Sheets About Science, Ethics, Research Technique and Institute
      • Secretary’s Advisory Committee on Genetics, Health, and Society
      • Pharmacogenomics: Applications to Patient Care
      • Pharmacogenomics: Applications to Patient Care, second edition
      • Pharmacogenomics: An Introduction and Clinical Perspective
      • Pharmacogenomics Challenges and Opportunities in Therapeutic Implementation
      • Psychiatric Pharmacogenomics
      • The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Overcoming Challenges of Real-World Implementation.
      • Pharmacogenomics and individualized medicine: translating science into practice
      • *A clinician-driven automated system for integration of pharmacogenetic interpretations into an electronic medical record.
      • Development and implementation of a pharmacist-managed clinical pharmacogenetics service
      • A clinician-driven automated system for integration of pharmacogenetic interpretations into an electronic medical record.
      • Pharmacogenomics Education Program (PharmGenEd)
      • Pharmacogenomics: Applications to Patient Care, third edition
    • E5: To Identify the need to refer a patient to a genetic specialist or genetic counselor
      • Cancer Topics: National Cancer Institute
      • National Human Genome Research Institute – Fact Sheets About Science, Ethics, Research Technique and Institute
      • Secretary’s Advisory Committee on Genetics, Health, and Society
      • Genetics Home Reference
      • Genetics Home Reference
      • Clopidogrel
      • Warfarin
      • Thiopurines (Azathioprine, Mercaptopurine and Thioguanine)